{"id":"flusalan","rwe":[],"tags":[{"label":"flusalan","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Kappa-type opioid receptor","category":"target"},{"label":"OPRK1","category":"gene"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"fluorsalan","offLabel":[],"synonyms":["fluorosalan","fluorophene","fluorsalan","flusalan"],"timeline":[],"approvals":[],"brandName":"Fluorsalan","ecosystem":[],"mechanism":{"target":"Kappa-type opioid receptor, Mu-type opioid receptor","targets":[{"gene":"OPRK1","source":"DrugCentral","target":"Kappa-type opioid receptor","protein":"Kappa-type opioid receptor"}],"modality":"Small Molecule","drugClass":"flusalan","explanation":"Imagine your brain has special locks that control pain signals. Fluorsalan is a key that fits into these locks, called kappa opioid receptors, and turns them on to help reduce pain. This can be helpful for people who need pain relief without the risks of other opioids.","oneSentence":"Fluorsalan works by binding to and activating kappa-type opioid receptors in the brain, which can help reduce pain without the same risks as traditional opioids.","technicalDetail":"Fluorsalan acts as a kappa opioid receptor agonist, binding to the receptor and inducing a conformational change that activates G-protein signaling pathways, ultimately leading to analgesic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3236","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=flusalan","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:33:55.813311","biosimilars":[],"competitors":[{"drugName":"alvimopan","drugSlug":"alvimopan","fdaApproval":"2008-05-20","patentExpiry":"Feb 12, 2030","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"amiodarone","drugSlug":"amiodarone","fdaApproval":"1985-12-24","patentExpiry":"Mar 13, 2029","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"astemizole","drugSlug":"astemizole","fdaApproval":"1988-12-31","relationship":"same-target"},{"drugName":"bisacodyl","drugSlug":"bisacodyl","fdaApproval":"2004-05-10","relationship":"same-target"},{"drugName":"buprenorphine","drugSlug":"buprenorphine","fdaApproval":"1981-12-29","patentExpiry":"Sep 5, 2031","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"butorphanol","drugSlug":"butorphanol","fdaApproval":"1978-08-22","genericCount":6,"patentStatus":"Off-patent — generic available","relationship":"same-target"},{"drugName":"cannabidiol","drugSlug":"cannabidiol","fdaApproval":"2018-06-25","patentExpiry":"Oct 13, 2035","patentStatus":"Patent protected","relationship":"same-target"},{"drugName":"cefapirin","drugSlug":"cefapirin","fdaApproval":"1974-03-12","relationship":"same-target"},{"drugName":"chlorpromazine","drugSlug":"chlorpromazine","fdaApproval":"1957-09-18","patentStatus":"Unknown","relationship":"same-target"},{"drugName":"clotrimazole","drugSlug":"clotrimazole","fdaApproval":"1975-02-03","patentExpiry":"May 26, 2042","patentStatus":"Patent protected","relationship":"same-target"}],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"flusalan","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[{"drugId":"alvimopan","brandName":"alvimopan","genericName":"alvimopan","approvalYear":"2008","relationship":"same-target"},{"drugId":"amiodarone","brandName":"amiodarone","genericName":"amiodarone","approvalYear":"1985","relationship":"same-target"},{"drugId":"astemizole","brandName":"astemizole","genericName":"astemizole","approvalYear":"1988","relationship":"same-target"},{"drugId":"bisacodyl","brandName":"bisacodyl","genericName":"bisacodyl","approvalYear":"2004","relationship":"same-target"},{"drugId":"buprenorphine","brandName":"buprenorphine","genericName":"buprenorphine","approvalYear":"1981","relationship":"same-target"},{"drugId":"butorphanol","brandName":"butorphanol","genericName":"butorphanol","approvalYear":"1978","relationship":"same-target"},{"drugId":"cannabidiol","brandName":"cannabidiol","genericName":"cannabidiol","approvalYear":"2018","relationship":"same-target"},{"drugId":"cefapirin","brandName":"cefapirin","genericName":"cefapirin","approvalYear":"1974","relationship":"same-target"},{"drugId":"chlorpromazine","brandName":"chlorpromazine","genericName":"chlorpromazine","approvalYear":"1957","relationship":"same-target"},{"drugId":"clotrimazole","brandName":"clotrimazole","genericName":"clotrimazole","approvalYear":"1975","relationship":"same-target"}],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"UNII":"80OFG3WPYD","CHEBI":"CHEBI:135715","INN_ID":"2141","UMLSCUI":"C2826091","ChEMBL_ID":"CHEMBL283552","KEGG_DRUG":"D04222","PUBCHEM_CID":"20906","MESH_SUPPLEMENTAL_RECORD_UI":"C013535"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Pain"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Fluorsalan, also known as flusalan, is a small molecule drug class targeting the kappa-type opioid receptor. It is currently owned by an unknown entity, and its commercial status is unclear. Fluorsalan is being developed to treat various conditions, but its exact indications and approval status are unknown. As a kappa opioid receptor agonist, fluorsalan works by binding to and activating these receptors, which can produce analgesic effects without the same level of respiratory depression as traditional opioids. Further research is needed to fully understand its safety and efficacy profile.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}